Author

@TheDrugMoney TheDrugMoney

Single-name HIMS perma-bull megaphone riding the peptide 'category 1' catalyst

Posts high-frequency bullish HIMS calls, escalating long-dat

trader score
-0.23
hit rate
60%
mean α
-0.30%
signals 14d
9

Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.

Their picks, scored

Across their last 10 scored bets: 60% hit rate, -0.30% mean alpha, trader score -0.23. Their last-14d mentions, direction-adjusted, have moved -4.1% since posting (mean over 4 mentions with price data).

Recent signals9receipts included
date (PT)tickerauthorsentwhat they saidsince thenreceipt
2026-10-16·@TheDrugMoney·Declares that the US stock market has entered an existential decline.·
2026-10-15HIMS@TheDrugMoney+0.60Claims peptide prohibitions are ending, a positive regulatory development for HIMS.-5.7%
2026-10-15VOO@TheDrugMoney+0.15Jokes about a tiny three-share VOO purchase saving the market.-1.5%
2026-10-14·@TheDrugMoney·Declares that a collapse of the US stock market has begun.·
2026-10-12HIMS@TheDrugMoney+0.70Strongly argues investors should not ignore HIMS before a peptide-category catalyst.-9.6%
2026-10-09·@TheDrugMoney·Reports that US auto-loan balances total $1.71 trillion and exceed credit-card debt.·
2026-10-07·@TheDrugMoney·Explicitly declares that a stock-market collapse has begun and endorses Michael Burry's bearish view.·
2026-10-06·@TheDrugMoney·Warns that nearly four years of 20% market gains resembles the late-1990s bubble setup.·
2026-10-04TSLA@TheDrugMoney+0.25Positively describes Tesla self-driving's effect on a long trip.+0.4%

Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.